add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Ontario Expands Access to Cancer DrugGovernment of Ontario News - 2 hours ago Avastin (or bevacizumab) is an intravenous chemotherapeutic agent typically administered at hospitals. Avastin has been funded in Ontario since July 2008 as ... Gene increases effectiveness of drugs used to fight cancer and allows ...Webnewswire.com - Nov 28, 2009 However, the most relevant fact was found in the breast cancer cell line MCF-7, in which the dose of the chemotherapeutic agent, doxorubicin, was reduced by ... Gene Increases Effectiveness of Drugs Used to Fight Cancer and Allows ...Science Daily (press release) - Nov 25, 2009 However, the most relevant fact was found in the breast cancer cell line MCF-7, in which the dose of the chemotherapeutic agent, doxorubicin, was reduced by ... Bioniche Strengthens the International Patent Portfolio for its MCC Technology ...PR Newswire (press release) - Nov 24, 2009 This patent's claims relate to medicament compositions of MCC or M-DNA and a chemotherapeutic agent for inhibiting the growth of animal or human cancer ... Gene Increases Effectiveness Of Drugs Used To Fight Cancer, Allows Dosage ...RedOrbit - Nov 24, 2009 However, the most relevant fact was found in the breast cancer cell line MCF-7, in which the dose of the chemotherapeutic agent, doxorubicin, was reduced by ... CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 in ...WELT ONLINE - Nov 24, 2009 CytRx holds the exclusive worldwide rights to INNO-206, a prodrug derivative of the commonly prescribed chemotherapeutic agent doxorubicin. ... Fort Worth Woman Takes 'No Chemo' Cancer ApproachCBS 11 - - Nov 23, 2009 "It turns out that our own body makes a chemotherapeutic agent already," the doctor explained. "It has already been patented. If you eat enough broccoli and ... Poniard Announces $7.4 Million FinancingPR Newswire (press release) - Nov 23, 2009 Picoplatin is an intravenous chemotherapeutic, designed to treat solid tumors that are resistant to existing platinum-based cancer therapies. ... Transgene: First Patient enrolled in Phase I Trial of TG4023 forEthio Planet News - Nov 21, 2009 TG4023 has a unique mechanism of action that converts a non-cytotoxic pro-drug, 5-FC, into 5-FU, a classic chemotherapeutic agent. Transgene's Phase I trial ... Children's Hearing Loss From Cisplatin Chemotherapy Associated With Gene VariantsMedscape - - Nov 20, 2009 Cisplatin is a highly effective platinum-based chemotherapeutic agent whose anticancer action is the result of platinum complexes that bind and cause DNA ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
